Veterans

VA Leads Innovation: Psychedelic-Assisted Therapy Study for Veterans with PTSD & AUD (2024)

Robert Yrshus / December 31, 2024

Introduction In December 2024, the VA launched a groundbreaking study on MDMA-assisted therapy, targeting veterans with PTSD and alcohol use […]

MDMA, Patient Research, PTSD, Stress, Veterans

Healing for Heroes: VA’s Groundbreaking Study on Psychedelic-Assisted Therapy (2024)

Robert Yrshus / December 31, 2024

Introduction In December 2024, the U.S. Department of Veterans Affairs (VA) announced its first funded study on the benefits of

Cannabis, Provider Research, PTSD, Veterans

VA Cannabis Recommendations: A New Era in Veteran Care (2023, Endocannabinoid Medicine Group)

Robert Yrshus / December 31, 2024

Introduction In November 2023, the U.S. Senate approved bipartisan legislation enabling VA doctors to recommend medical cannabis. This policy shift

Cannabis, Medical Marijuana, Patient Research, PTSD, Veterans

Breaking Barriers: Senate Supports Veterans’ Access to Medical Cannabis (2023, Endocannabinoid Medicine Group)

Robert Yrshus / December 31, 2024

Introduction In November 2023, the Senate approved a bipartisan bill to allow Veterans Affairs (VA) doctors to recommend medical cannabis

VitalPoint Technologies, Inc.

Disclaimer

None of the statements in this announcement or via any web sites linked herein have been evaluated by the FDA. Furthermore, none of the statements in this announcement or any web sites linked herein should be construed as dispensing medical advice or making claims regarding the cure of diseases. You should consult a licensed health care professional before starting any supplement, dietary, or exercise program, especially if you are pregnant or have any pre-existing injuries or medical conditions. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any diseases.